RESEARCH-USE BIOSIMILAR ANTIBODY

Bleselumab

Monoclonal antibody · IgG4

TNFRSF5IgG4RUO

Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (Kd: 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection.

TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-714
CATALOG NUMBERSC-BS-714
MOLECULAR WEIGHTApprox. 144.6 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (Kd: 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection.

Bleselumab is a recombinant research-use antibody directed against TNFRSF5.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Bleselumab | StellaCyte